Clearside Biomedical, Inc. - Common Stock, $0.001 par value (CLSD)

CUSIP: 185063104

Q4 2017 13F Holders as of 31 Dec 2017

Type / Class
Equity / Common Stock, $0.001 par value
Shares outstanding
76,991,404
Total 13F shares
12,327,157
Share change
-765,963
Total reported value
$86,290,610
Price per share
$7.00
Number of holders
52
Value change
-$5,570,945
Number of buys
24
Number of sells
21

Quarterly Holders Quick Answers

What is CUSIP 185063104?
CUSIP 185063104 identifies CLSD - Clearside Biomedical, Inc. - Common Stock, $0.001 par value in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of Clearside Biomedical, Inc. - Common Stock, $0.001 par value (CLSD) as of Q4 2017

As of 31 Dec 2017, Clearside Biomedical, Inc. - Common Stock, $0.001 par value (CLSD) was held by 52 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 12,327,157 shares. The largest 10 holders included WELLINGTON MANAGEMENT GROUP LLP, Cormorant Asset Management, LLC, BlackRock Inc., Hillhouse Capital Management, Ltd., Rock Springs Capital Management LP, Vanguard Group Inc, PERCEPTIVE ADVISORS LLC, FMR LLC, SPHERA FUNDS MANAGEMENT LTD., and FIRST MANHATTAN CO. This page lists 52 institutional shareholders reporting positions in this security for the Q4 2017 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.